S. Cure

853 total citations
39 papers, 565 citations indexed

About

S. Cure is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, S. Cure has authored 39 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 17 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in S. Cure's work include Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (13 papers) and HIV/AIDS drug development and treatment (8 papers). S. Cure is often cited by papers focused on Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (13 papers) and HIV/AIDS drug development and treatment (8 papers). S. Cure collaborates with scholars based in United Kingdom, United States and Switzerland. S. Cure's co-authors include F. Bianic, Charles M. Morin, Zalmaï Hakimi, Makoto Uchiyama, James K. Walsh, Damien Léger, Geoffrey Dusheiko, Sandra Gavart, Seina Lee and Michael Happich and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Journal of Affective Disorders.

In The Last Decade

S. Cure

36 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Cure United Kingdom 16 215 211 93 64 60 39 565
Min He China 14 199 0.9× 80 0.4× 39 0.4× 54 0.8× 13 0.2× 39 546
Gilbert L’Italien United States 15 307 1.4× 318 1.5× 24 0.3× 35 0.5× 48 0.8× 24 670
Essa A. Mohamed United States 12 422 2.0× 384 1.8× 43 0.5× 17 0.3× 4 0.1× 20 788
Mehrtash Hashemzadeh United States 16 166 0.8× 57 0.3× 14 0.2× 16 0.3× 24 0.4× 67 1.1k
Sasha Deutsch‐Link United States 11 191 0.9× 143 0.7× 22 0.2× 10 0.2× 4 0.1× 22 379
Rosirene Paczkowski United States 13 84 0.4× 29 0.1× 33 0.4× 13 0.2× 65 1.1× 42 528
Lucas M. Donovan United States 15 58 0.3× 25 0.1× 74 0.8× 72 1.1× 21 0.3× 67 711
P. Bramley United Kingdom 12 175 0.8× 161 0.8× 27 0.3× 6 0.1× 4 0.1× 18 533
Wiro B. Stam Netherlands 13 129 0.6× 18 0.1× 14 0.2× 10 0.2× 39 0.7× 22 648
Jiamin Yin Hong Kong 11 263 1.2× 53 0.3× 29 0.3× 9 0.1× 4 0.1× 18 620

Countries citing papers authored by S. Cure

Since Specialization
Citations

This map shows the geographic impact of S. Cure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Cure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Cure more than expected).

Fields of papers citing papers by S. Cure

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Cure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Cure. The network helps show where S. Cure may publish in the future.

Co-authorship network of co-authors of S. Cure

This figure shows the co-authorship network connecting the top 25 collaborators of S. Cure. A scholar is included among the top collaborators of S. Cure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Cure. S. Cure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagenlehner, Flo ri an, et al.. (2025). Efficacy of treatment options for complicated urinary tract infections including acute pyelonephritis: a systematic literature review and network meta-analysis. Journal of Comparative Effectiveness Research. 14(3). e240214–e240214. 2 indexed citations
2.
Cure, S., et al.. (2025). The motion of catalytically active colloids approaching a surface. Soft Matter. 21(13). 2541–2547.
3.
Murray, Robert, et al.. (2025). The Cost of Adrenal Insufficiency in England—Analysis of NHS HES Data. Clinical Endocrinology. 102(6). 611–617. 1 indexed citations
4.
Tsochatzis, Emmanuel, Philip N. Newsome, Stephen Ryder, et al.. (2021). Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018. The European Journal of Health Economics. 22(4). 505–518. 26 indexed citations
5.
6.
Soini, Erkki, Taru Hallinen, Mélanie Brignone, et al.. (2016). Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland. Expert Review of Pharmacoeconomics & Outcomes Research. 17(3). 293–302. 18 indexed citations
7.
Igarashi, Ataru, et al.. (2016). Cost–utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan. Current Medical Research and Opinion. 33(1). 11–21. 15 indexed citations
8.
Pfeil, Alena M., Oliver Reich, S. Cure, et al.. (2015). Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C. PLoS ONE. 10(5). e0126984–e0126984. 34 indexed citations
9.
Cure, S., et al.. (2015). Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy. Journal of Medical Economics. 18(9). 678–690. 21 indexed citations
10.
Cure, S., et al.. (2015). Cost-Effectiveness of Apremilast In Psoriatic Arthritis In Scotland. Value in Health. 18(7). A644–A644. 1 indexed citations
11.
12.
Younossi, Zobair M., et al.. (2014). P718 ESTIMATING HEALTH STATUS USING EQ5D FOR CHRONIC HEPATITIS C (CH-C) PATIENTS TREATED WITH SOFOSBUVIR (SOF) CONTAINING REGIMENS. Journal of Hepatology. 60(1). S308–S308. 2 indexed citations
13.
Igarashi, Ataru, et al.. (2014). Cost-Utility Analysis Of Sofosbuvir For Treatment Of Genotype2 Chronic Hepatitis C In Japan. Value in Health. 17(7). A368–A368. 4 indexed citations
14.
15.
Hechmati, Guy, S. Cure, Vito Lorusso, et al.. (2013). Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study. Journal of Medical Economics. 16(5). 691–700. 46 indexed citations
16.
17.
Cowie, Martín, S. Cure, F. Bianic, et al.. (2011). Cost-Effectiveness of Highly Purified Omega-3 Polyunsaturated Fatty Acid Ethyl Esters in the Treatment of Chronic Heart Failure: Results of Markov Modelling in a UK Setting. European Journal of Heart Failure. 13(6). 681–689. 24 indexed citations
18.
Léger, Damien, Charles M. Morin, Makoto Uchiyama, et al.. (2011). Chronic insomnia, quality-of-life, and utility scores: Comparison with good sleepers in a cross-sectional international survey. Sleep Medicine. 13(1). 43–51. 104 indexed citations
19.
Diels, Joris, S. Cure, & Sandra Gavart. (2011). PIN7 The Comparative Efficacy of Telaprevir Versus Boceprevir in Treatment-Naive and Treatment-Experienced Patients with Genotype 1 Chronic Hepatitis. Value in Health. 14(7). A266–A266. 2 indexed citations
20.
Aballéa, Samuel, S. Cure, Claus Vogelmeier, & Anders Wirén. (2008). A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β2-agonists for asthma maintenance treatment in Germany. International Journal of Clinical Practice. 62(12). 1870–1879. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min He Breakdown of academic impact, for papers by Gilbert L’Italien Breakdown of academic impact, for papers by Essa A. Mohamed Breakdown of academic impact, for papers by Mehrtash Hashemzadeh Breakdown of academic impact, for papers by Sasha Deutsch‐Link Breakdown of academic impact, for papers by Rosirene Paczkowski Breakdown of academic impact, for papers by Lucas M. Donovan Breakdown of academic impact, for papers by P. Bramley Breakdown of academic impact, for papers by Wiro B. Stam Breakdown of academic impact, for papers by Jiamin Yin
Rankless by CCL
2026